In this article, we decided to focus on Omnicell's ROE. Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital.

Omnicell (NASDAQ:OMCL) has had a rough three months with its share price down 21%. We, however decided to study ...

Headquartered in Mountain View, CA, Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply ...

Omnicell (NASDAQ:OMCL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” ...

To gain a panoramic view of Omnicell's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings ...

Swiss National Bank boosted its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 0.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 90,500 shares of the company’s stock ...

Omnicell said it has launched a nationwide search ... Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 ...